Information

Description

Retatrufei 32.5mg Double Vial Chamber Pen is a next-generation metabolic peptide formulated to support appetite control, improve metabolic efficiency, and assist in fat reduction protocols. It works by targeting key metabolic signalling pathways involved in energy regulation and nutrient utilisation.

This product is supplied in a double vial chamber pen, meaning the peptide and diluent are stored separately inside the device and only mix when activated prior to first use. This helps maintain peptide stability and potency until the moment of preparation. Unlike prefilled pens, Retatrufei 32.5mg Double Vial Chamber Pen requires activation to mix the solution before administration but still offers convenient pen-based dosing once prepared.

Benefits
� Supports appetite control
� Enhances fat metabolism
� Supports metabolic efficiency
� May improve insulin sensitivity
� Supports structured weight-management programs
� Double chamber design improves stability and shelf life
� Convenient pen-based dosing once activated

Side Effects
� Nausea
� Mild stomach discomfort
� Temporary fatigue
� Headache
� Possible reduced appetite
� Rare: dizziness or mild hypoglycaemia symptoms

Dosages & Protocol
Beginner: 2mg once weekly
Intermediate: 4�6mg once weekly
Advanced: 8�10mg once weekly (based on tolerance and protocol goals)

Dose escalation should be gradual to reduce gastrointestinal side effects.

How to Administer
� PLEASE SEE ENCLOSED LEAFLET FOR DETAILED INSTRUCTIONS

Storage
� After activation and mixing, store refrigerated.
� Do not freeze.
� Protect from direct light.
� Keep out of reach of children.

Half-Life & Detectability
Long-acting metabolic peptide profile designed for weekly administration.
Detectability: Not typically included in standard athletic drug screening panels.

For athletes subject to drug testing, it is important to consider these detection times and plan accordingly to avoid positive tests for banned substances.